Control of variceal bleeding in a patient with severe haemophilia A and factor VIII inhibitors using a transjugular intrahepatic portosystemic shunt.
Hurst
E
E
Talks
K
K
Hanley
J
J
D000368:Aged; D019774:Blood Coagulation Factor Inhibitors / Q000032:analysis*; D001779:Blood Coagulation Factors / Q000627:therapeutic use*; D004932:Esophageal and Gastric Varices / Q000150:complications*; D005169:Factor VIII / Q000037:antagonists & inhibitors*; D015942:Factor VIIa / Q000627:therapeutic use*; D006471:Gastrointestinal Hemorrhage / Q000209:etiology / Q000628:therapy*; D006467:Hemophilia A / Q000150:complications* / Q000188:drug therapy; D006526:Hepatitis C / Q000150:complications; D006801:Humans; D008297:Male; D019168:Portasystemic Shunt, Transjugular Intrahepatic; D011994:Recombinant Proteins / Q000627:therapeutic use; D016896:Treatment Outcome
D019774:Blood Coagulation Factor Inhibitors; D001779:Blood Coagulation Factors; D011994:Recombinant Proteins; D005169:Factor VIII; C103587:recombinant FVIIa; C065655:anti-inhibitor coagulant complex; D015942:Factor VIIa